<?xml version="1.0" encoding="UTF-8"?>
<resource xmlns="http://datacite.org/schema/kernel-4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.18453/rosdok_id00003164</identifier>
  <creators>
    <creator>
      <creatorName nameType="Personal">Lu, Lili</creatorName>
      <givenName>Lili</givenName>
      <familyName>Lu</familyName>
      <nameIdentifier nameIdentifierScheme="GND" schemeURI="http://d-nb.info/gnd/">http://d-nb.info/gnd/1241495157</nameIdentifier>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/">https://orcid.org/0000-0001-6638-624X</nameIdentifier>
    </creator>
  </creators>
  <titles>
    <title>Identification of the microsatellite stability status and inhibitor of NF-kappa-B expression levels as biomarkers to predict sensitivity to pharmaceutical curcumin in colorectal cancer cells</title>
  </titles>
  <publisher>Universität Rostock</publisher>
  <publicationYear>2021</publicationYear>
  <resourceType resourceTypeGeneral="Text" />
  <subjects>
    <subject xml:lang="en" schemeURI="http://dewey.info/" subjectScheme="dewey">500 Natural sciences</subject>
    <subject xml:lang="en" schemeURI="http://dewey.info/" subjectScheme="dewey">610 Medical sciences Medicine</subject>
  </subjects>
  <dates>
    <date dateType="Created">2021</date>
  </dates>
  <language>en</language>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="PURL">http://purl.uni-rostock.de/rosdok/id00003164</alternateIdentifier>
    <alternateIdentifier alternateIdentifierType="URN">urn:nbn:de:gbv:28-rosdok_id00003164-0</alternateIdentifier>
  </alternateIdentifiers>
  <descriptions>
    <description descriptionType="Abstract">The present study aimed at 1) testing the sensitivity of CRC cell lines with defined molecular alterations to curcumin; 2) mechanistically analyzing sensitive CRC cell lines in order to identify the mode-of-action; 3) identifying biomarkers associated with curcumin sensitivity; 4) establishing a predictive model using biomarkers to predict the sensitivity of additional CRC cell line to curcumin.</description>
  </descriptions>
</resource>
